The propranolol recall announced on 16 November 2026 covers one lot of Breckenridge Pharmaceutical’s Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, after the company found it shared an intermediate material with a separate batch in which metal contamination was detected. The affected 100-count bottles (lot PK25110035, NDC 51991-817-01, expiry May 2029) were shipped to US wholesalers and pharmacies between 26 October and 4 November 2026, so some may already be in patients’ medicine cabinets.
The recall is voluntary, nationwide and reaches the consumer level, and Breckenridge says it is acting with the knowledge of the US Food and Drug Administration. No adverse events linked to the problem have been reported so far.
Key takeaways on the propranolol recall
- Only one lot is affected: propranolol HCl ER capsules 60 mg, lot PK25110035, expiry 05/2029, NDC 51991-817-01.
- The concern is possible metal particles, which could cut soft tissue in the mouth, oesophagus, stomach or intestine.
- Breckenridge says it knows of no adverse events assessed as related to the recall.
- Product went out nationwide from 26 October to 4 November 2026; the capsules were made by Adare Pharma Solutions.
- Patients holding this lot should contact their prescriber or pharmacist promptly for a replacement from a different lot rather than simply going without a beta blocker.
How to check whether your bottle is affected
The lot number and expiry date are printed on the bottle label, usually near the barcode. Pharmacies often repackage medicines into their own vials, so if your label does not show the manufacturer’s lot, ask the pharmacy that filled the prescription; it can check its dispensing records against the recalled lot.
| Detail | Recalled product |
|---|---|
| Product | Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg |
| Pack | Bottle of 100 capsules |
| NDC | 51991-817-01 |
| Lot | PK25110035 |
| Expiry | May 2029 |
| Labeler / maker | Breckenridge Pharmaceutical / Adare Pharma Solutions |
| Shipped | 26 Oct to 4 Nov 2026, nationwide, to wholesalers and pharmacies |
| Reported related adverse events | None, per the company |
| Recall helpline (Qualanex) | 1-855-736-0807, Mon to Fri, 9 am to 5 pm ET |
Other strengths of Breckenridge propranolol, immediate-release propranolol tablets and propranolol from other manufacturers are not part of this action.
Why the lot was pulled even though no metal was found in it
The recall is precautionary in an important sense. According to the company’s recall notice, contamination was confirmed in a different lot that was never released for sale. Investigators traced it to an intermediate material, and lot PK25110035 was made from that same intermediate. Because the shared input is the suspected source, the released lot is being treated as potentially affected.
Extended-release capsules are typically built from coated pellets or beads produced in earlier manufacturing steps, then filled into capsules. A problem introduced upstream, for example from worn equipment shedding fragments during processing, can therefore travel into more than one finished batch. That is why manufacturers usually trace and quarantine every lot that touched the same intermediate once a defect is confirmed.
What patients should do now
Breckenridge’s instruction is direct: “Consumers should immediately stop taking product from the lot subject to this recall.” It also tells patients to contact a physician or healthcare provider for advice and replacement, and to return unused capsules to the pharmacy where they were obtained.
There is a practical nuance. Propranolol labels warn that stopping a beta blocker abruptly can worsen angina and, in some people, trigger heart attacks or rhythm problems, so the safest path is to get a replacement supply from an unaffected lot the same day. Pharmacists can usually swap the bottle quickly, and many will dispense the same strength from another manufacturer. If you cannot reach your pharmacy or prescriber promptly, call them before deciding to skip doses, especially if you take propranolol for angina, irregular heartbeat or after a heart attack.
Anyone who has swallowed capsules from this lot and develops mouth pain, trouble swallowing, chest or abdominal pain, vomiting blood or black stools should seek medical care. Problems can be reported to the FDA’s MedWatch programme online or by phone at 1-800-332-1088.
Who takes extended-release propranolol
Propranolol is one of the oldest and most widely used beta blockers. The once-daily extended-release form is prescribed for high blood pressure, angina, migraine prevention and a heart-muscle condition called hypertrophic subaortic stenosis, and doctors also use propranolol for essential tremor and, off label, for performance anxiety. The 60 mg capsule is a common starting or maintenance dose, which is why even a single-lot recall can touch many households.
For readers following other cardiovascular news, our coverage of the CHMP opinion on AstraZeneca’s Baxfendy blood pressure pill looks at where newer hypertension drugs fit, and our pharmaceutical news section tracks other drug safety actions.
Market context: a large, generic-heavy category
Beta blockers such as propranolol sit inside the broader hypertension treatment market, which depends heavily on low-cost generics made by many suppliers. According to Acumen Research and Consulting, the global hypertension drugs market was valued at USD 26.5 billion in 2023 and is projected to reach USD 38.3 billion by 2032, a compound annual growth rate of 4.2% from 2024 to 2032. The same report notes that primary hypertension accounts for the largest share of demand and that Asia-Pacific is expected to grow fastest.
Thin generic margins and multi-step supply chains are one reason quality events like this recur across the industry. A single contaminated intermediate can idle several batches, and recalls of widely used heart and blood pressure drugs tend to draw outsized attention because so many people take them daily.
What is still unknown
- The company has not said how many bottles were in the recalled lot or how many reached patients.
- The type and size of the metal found in the unreleased batch have not been disclosed.
- The FDA has not yet assigned a recall classification (Class I, II or III); that typically appears later in the agency’s enforcement report.
- It is not yet public whether the shared intermediate was used for any other products.
FAQ: propranolol recall
Which propranolol is being recalled?
Only Breckenridge’s propranolol HCl extended-release 60 mg capsules in 100-count bottles from lot PK25110035, expiry May 2029, NDC 51991-817-01.
Should I stop taking propranolol?
Stop using capsules from the recalled lot, but contact your pharmacist or doctor right away for a replacement from an unaffected lot. Do not stop propranolol therapy altogether without medical advice, because sudden withdrawal of a beta blocker can be risky for some heart patients.
Has anyone been hurt by the recalled capsules?
Breckenridge says it is not aware of any adverse events assessed as related to the recall as of 16 November 2026.
How do I return recalled propranolol?
Take unused capsules back to the pharmacy that dispensed them. Questions about the recall can go to Qualanex at 1-855-736-0807 on weekdays.
Sources: Breckenridge Pharmaceutical recall notice (16 November 2026); FDA MedWatch. Market data: Acumen Research and Consulting, Hypertension Drugs Market report. This article is for information only and is not medical advice; speak to your pharmacist or doctor about your medicines. Last updated 17 November 2026.

